Sun Pharma Says It Bought U.S. Based Injectables Maker Pharmalucence
This article was originally published in PharmAsia News
Executive Summary
Sun Pharmaceutical Industries said one of its U.S. subsidiaries had acquired Pharmalucence, a U.S.-based maker of sterile injectables for cancer as a company focused on radiopharmaceuticals.